Acetonitrile → HCID 131732895, compound
Reaction equation
[CH3:1][C@H:2]1[CH2:33][C:32]([CH3:34])=[CH:31][C@@H:30]([CH2:35][CH:36]=[CH2:37])[C:28](=[O:29])[CH2:27][C@H:26]([OH:38])[C@@H:25]([CH3:39])[C@@H:24](/[C:40](/[CH3:51])=[CH:41]/[C@H:42]2[CH2:47][C@@H:46]([O:48][CH3:49])[C@H:45]([OH:50])[CH2:44][CH2:43]2)[O:23][C:21](=[O:22])[C@H:20]2[N:15]([CH2:16][CH2:17][CH2:18][CH2:19]2)[C:13](=[O:14])[C:11](=[O:12])[C@:9]2([OH:52])[O:10][C@@H:5]([C@@H:6]([O:54][CH3:55])[CH2:7][C@H:8]2[CH3:53])[C@@H:4]([O:56][CH3:57])[CH2:3]1.[OH:58][CH:59]1[O:78][C@H:77]([CH2:79][OH:80])[C@@H:64]([O:65][C@@H:66]2[O:74][C@H:73]([CH2:75][OH:76])[C@H:71]([OH:72])[C@H:69]([OH:70])[C@H:67]2[OH:68])[C@H:62]([OH:63])[C@H:60]1[OH:61].C(#N)C>O>[CH3:1][C@H:2]1[CH2:33][C:32]([CH3:34])=[CH:31][C@@H:30]([CH2:35][CH:36]=[CH2:37])[C:28](=[O:29])[CH2:27][C@H:26]([OH:38])[C@@H:25]([CH3:39])[C@@H:24](/[C:40](/[CH3:51])=[CH:41]/[C@H:42]2[CH2:47][C@@H:46]([O:48][CH3:49])[C@H:45]([OH:50])[CH2:44][CH2:43]2)[O:23][C:21](=[O:22])[C@H:20]2[N:15]([CH2:16][CH2:17][CH2:18][CH2:19]2)[C:13](=[O:14])[C:11](=[O:12])[C@:9]2([OH:52])[O:10][C@@H:5]([C@@H:6]([O:54][CH3:55])[CH2:7][C@H:8]2[CH3:53])[C@@H:4]([O:56][CH3:57])[CH2:3]1.[OH:58][CH:59]1[O:78][C@H:77]([CH2:79][OH:80])[C@@H:64]([O:65][C@@H:66]2[O:74][C@H:73]([CH2:75][OH:76])[C@H:71]([OH:72])[C@H:69]([OH:70])[C@H:67]2[OH:68])[C@H:62]([OH:63])[C@H:60]1[OH:61]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- -50 °C
Procedure
A formulation of tacrolimus (TAC) was produced using TAC and lactose (LAC) in ratio 1:1. The TAC:LAC 1:1 formulation was prepared using the ultra-rapid freezing (URF) process. The compositions were prepared by dissolving TAC and LAC at a 1:1 ratio and 0.75% solids in a 60/40 mixture of acetonitrile and water. The solution of drug and excipient was applied to the surface of a solid substrate, which is cooled using a cryogenic substrate maintained at −50° C. The frozen compositions were then collected and the solvent was removed by lyophilization using a VirTis Advantage Lyophilizer (VirTis Company, Inc. Gardiner, N.Y.). The dried powders were stored at room temperature under vacuum.
Workup
- customThe compositions were prepared
- temperatureis cooled
- customThe frozen compositions were then collected
- customthe solvent was removed by lyophilization
- customwere stored at room temperature under vacuum
Sources & evidence
- ORD record
- ord-b05b75ab484c4a78983e6c2b23821ab4
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09044391B2
Reaction notes
Loading…